Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada; Robarts Clinical Trials, Inc, London, Ontario, Canada.
Department of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Clin Gastroenterol Hepatol. 2020 Oct;18(11):2500-2509.e1. doi: 10.1016/j.cgh.2020.01.023. Epub 2020 Jan 25.
BACKGROUND & AIMS: Patients with inflammatory bowel diseases (IBDs) require repeated health care encounters, although the focus of care differs when patients are seen in ambulatory, emergency department (ED), or inpatient settings. We examined contemporary trends and disparities in IBD-related health care visits.
We used data from the National Ambulatory Medical Care Survey, the Nationwide Emergency Department Sample, and the National Inpatient Sample to estimate the total number of annual IBD-related visits from 2005 through 2016. We performed logistic regression analyses to test temporal linear trends. Slope and differences in distributions of patient demographics were compared across time and treatment settings.
From 2005 through 2016, approximately 2.2 million IBD-related ambulatory visits (95 CI, 1.9-2.5) occurred annually on average, increasing by 70.3% from the time period of 2005 to 2007 through the time period of 2008 to 2010, and decreasing by 19.8% from the time period of 2011 to 2013 through the time period of 2014 to 2016. An average of 115,934 IBD-related ED visits (95% CI, 113,758-118,111) and 89,111 IBD-related hospital discharges (95% CI, 87,416-90,807) occurred annually. Significant increases in the rate of IBD-related ED visits (3.2 visits/10,000 encounters; P < .0001) and hospital discharges (6.0 discharges/10,000 encounters; P < .0001) were observed from 2005 through 2016. The proportion of patients paying with private insurance decreased from 2005 through 2016, among all care settings. A greater proportion of young patients, patients with Crohn's disease, non-white patients, and patients with Medicare or Medicaid used hospital-based vs ambulatory services.
In an analysis of data from 3 large databases, we found that although IBD-related ambulatory visits stabilized to decreased from 2005 through 2016, rates of ED use and admission to the hospital have continued to increase with changes in patient demographics, over time and among care settings.
炎症性肠病(IBD)患者需要多次进行医疗保健,尽管在门诊、急诊部(ED)或住院环境中就诊时,治疗重点有所不同。我们研究了 IBD 相关医疗保健就诊的当代趋势和差异。
我们使用来自全国门诊医疗调查、全国急诊部样本和全国住院样本的数据,从 2005 年到 2016 年估计每年 IBD 相关就诊的总数。我们进行逻辑回归分析来检验时间线性趋势。比较不同时间和治疗环境下患者人口统计学特征的分布斜率和差异。
从 2005 年到 2016 年,平均每年约有 220 万次 IBD 相关的门诊就诊(95%置信区间,1.9-2.5),从 2005 年至 2007 年的时间段到 2008 年至 2010 年的时间段增加了 70.3%,而从 2011 年至 2013 年的时间段到 2014 年至 2016 年的时间段减少了 19.8%。平均每年有 115934 次 IBD 相关的 ED 就诊(95%置信区间,113758-118111)和 89111 次 IBD 相关的住院出院(95%置信区间,87416-90807)。从 2005 年到 2016 年,IBD 相关的 ED 就诊率(每 10000 次就诊 3.2 次就诊;P <.0001)和住院出院率(每 10000 次就诊 6.0 次出院;P <.0001)显著增加。在所有治疗环境中,自 2005 年至 2016 年,使用私人保险的患者比例下降。与门诊服务相比,年轻患者、克罗恩病患者、非白人患者和使用医疗保险或医疗补助的患者使用医院服务的比例更高。
在对来自 3 个大型数据库的数据进行分析后,我们发现,尽管 IBD 相关的门诊就诊率从 2005 年到 2016 年稳定下降,但随着患者人口统计学特征的变化,ED 使用和住院率仍在继续增加,且随时间推移和治疗环境而异。